Satish K Tickoo

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. doi request reprint Differential diagnosis of renal tumors with papillary architecture
    Satish K Tickoo
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Adv Anat Pathol 18:120-32. 2011
  2. ncbi request reprint Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia
    Satish K Tickoo
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Am J Surg Pathol 30:141-53. 2006
  3. ncbi request reprint Immunohistochemical expression of hypoxia inducible factor-1alpha and its downstream molecules in sarcomatoid renal cell carcinoma
    Satish K Tickoo
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Urol 177:1258-63. 2007
  4. ncbi request reprint Bone metastases from thyroid carcinoma: a histopathologic study with clinical correlates
    S K Tickoo
    Departments of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Arch Pathol Lab Med 124:1440-7. 2000
  5. ncbi request reprint Estrogen and progesterone-receptor-positive stroma as a non-tumorous proliferation in kidneys: a possible metaplastic response to obstruction
    Satish K Tickoo
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Mod Pathol 21:60-5. 2008
  6. doi request reprint Hypoxia-inducible factor and mammalian target of rapamycin pathway markers in urothelial carcinoma of the bladder: possible therapeutic implications
    Satish K Tickoo
    Department of Pathology Genitourinary Oncology Service, Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, Center, New York, NY, USA
    BJU Int 107:844-9. 2011
  7. doi request reprint Pathologic features of renal cortical tumors
    Satish K Tickoo
    Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USA
    Urol Clin North Am 35:551-61; v. 2008
  8. pmc TMPRSS2-ERG rearrangement in dominant anterior prostatic tumours: incidence and correlation with ERG immunohistochemistry
    Anuradha Gopalan
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Histopathology 63:279-86. 2013
  9. doi request reprint Role of immunohistochemistry in the evaluation of needle core biopsies in adult renal cortical tumors: an ex vivo study
    Hikmat A Al-Ahmadie
    Departments of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Am J Surg Pathol 35:949-61. 2011
  10. doi request reprint Carbonic anhydrase IX expression in clear cell renal cell carcinoma: an immunohistochemical study comparing 2 antibodies
    Hikmat A Al-Ahmadie
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Am J Surg Pathol 32:377-82. 2008

Detail Information

Publications67

  1. doi request reprint Differential diagnosis of renal tumors with papillary architecture
    Satish K Tickoo
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Adv Anat Pathol 18:120-32. 2011
    ..Close attention to the cytologic and growth pattern characteristics will allow us to arrive at the proper diagnosis in most cases, although sometimes immunohistochemistry and rarely genetic evaluation may be needed...
  2. ncbi request reprint Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia
    Satish K Tickoo
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Am J Surg Pathol 30:141-53. 2006
    ..Acquired cystic disease-associated RCC is the commonest tumor subtype in ESRD, and biologically it appears to be more aggressive than the other tumor subtypes in ESRD...
  3. ncbi request reprint Immunohistochemical expression of hypoxia inducible factor-1alpha and its downstream molecules in sarcomatoid renal cell carcinoma
    Satish K Tickoo
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Urol 177:1258-63. 2007
    ..We investigated the hypoxia inducible pathway marker immunohistochemical expression profile, and any potential therapeutic implications that such expression may have, in these tumors...
  4. ncbi request reprint Bone metastases from thyroid carcinoma: a histopathologic study with clinical correlates
    S K Tickoo
    Departments of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Arch Pathol Lab Med 124:1440-7. 2000
    ..Only limited information exists on the pathologic aspects of thyroid carcinomas with bone metastases, most large studies having concentrated mainly on their clinical features...
  5. ncbi request reprint Estrogen and progesterone-receptor-positive stroma as a non-tumorous proliferation in kidneys: a possible metaplastic response to obstruction
    Satish K Tickoo
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Mod Pathol 21:60-5. 2008
    ..Its association with obstructive changes suggests that it may represent a metaplastic change in the renal interstitial cells surrounding these obstructed epithelial structures...
  6. doi request reprint Hypoxia-inducible factor and mammalian target of rapamycin pathway markers in urothelial carcinoma of the bladder: possible therapeutic implications
    Satish K Tickoo
    Department of Pathology Genitourinary Oncology Service, Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, Center, New York, NY, USA
    BJU Int 107:844-9. 2011
    ....
  7. doi request reprint Pathologic features of renal cortical tumors
    Satish K Tickoo
    Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USA
    Urol Clin North Am 35:551-61; v. 2008
    ..The authors believe that the recently gained knowledge about molecular-driven antigen expression will play an important role in the characterization, development, and evaluation of targeted therapies in kidney cancer in the coming years...
  8. pmc TMPRSS2-ERG rearrangement in dominant anterior prostatic tumours: incidence and correlation with ERG immunohistochemistry
    Anuradha Gopalan
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Histopathology 63:279-86. 2013
    ..To study prostate cancer zonal differences in TMPRSS2-ERG gene rearrangement...
  9. doi request reprint Role of immunohistochemistry in the evaluation of needle core biopsies in adult renal cortical tumors: an ex vivo study
    Hikmat A Al-Ahmadie
    Departments of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Am J Surg Pathol 35:949-61. 2011
    ..Both extent and patterns must be considered for a definitive diagnosis...
  10. doi request reprint Carbonic anhydrase IX expression in clear cell renal cell carcinoma: an immunohistochemical study comparing 2 antibodies
    Hikmat A Al-Ahmadie
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Am J Surg Pathol 32:377-82. 2008
    ..Therefore, similar to the clone M75, NB100-417 can be used as a diagnostic and potentially a prognostic marker in CRCC, with the advantage of its commercial availability...
  11. pmc Sarcomatoid-variant renal cell carcinoma: treatment outcome and survival in advanced disease
    Ana M Molina
    Department of Medicine, Genitourinary Oncology Service, Weil Medical College of Cornell University, New York, NY, USA
    Am J Clin Oncol 34:454-9. 2011
    ..Sarcomatoid variant is a spindle cell phenotype of renal cell carcinoma (RCC), which is associated with a poor prognosis. We reviewed outcomes of systemic therapy for metastatic, sarcomatoid-variant RCC...
  12. pmc TMPRSS2-ERG gene fusion is associated with low Gleason scores and not with high-grade morphological features
    Samson W Fine
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Mod Pathol 23:1325-33. 2010
    ..These findings indicate that translocation/deletion of TMPRSS2-ERG is not associated with histological features of aggressive prostate cancer...
  13. ncbi request reprint Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model
    Sue Ellen Touma
    Department of Pharmacology, Weill Medical College of Cornell University, New York, New York 10021, USA
    Clin Cancer Res 11:3558-66. 2005
    ..Therefore, we tested whether combining histone deacetylase inhibitors with retinoic acid (RA) would restore RARbeta2 receptor expression, leading to increased growth inhibition in RCC cells...
  14. doi request reprint Chromophobe renal cell carcinoma: a clinicopathologic study of 203 tumors in 200 patients with primary resection at a single institution
    Christopher G Przybycin
    Department of Pathology, Urology Service, Memorial Sloan Kettering Cancer Center New York, NY 10065, USA
    Am J Surg Pathol 35:962-70. 2011
    ..On the basis of this long follow-up on a large number of cases, chromophobes seem to have better clinical outcomes than those reported for clear cell and papillary RCCs...
  15. pmc TMPRSS2-ERG gene fusion is not associated with outcome in patients treated by prostatectomy
    Anuradha Gopalan
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Cancer Res 69:1400-6. 2009
    ....
  16. pmc Clinical and pathologic impact of select chromatin-modulating tumor suppressors in clear cell renal cell carcinoma
    A Ari Hakimi
    Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Eur Urol 63:848-54. 2013
    ..PBRM1, SETD2, and BAP1 are located in close proximity to VHL within a commonly lost (approximately 90%) 3p locus. To date, the clinical and pathologic significance of mutations in these novel candidate tumor suppressors is unknown...
  17. ncbi request reprint Patterns of morphologic alteration in residual rectal carcinoma following preoperative chemoradiation and their association with long-term outcome
    Jinru Shia
    Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Am J Surg Pathol 28:215-23. 2004
    ..Our results demonstrate distinct morphologic features in treated rectal carcinomas that are prognostically relevant...
  18. pmc Prostate cancer topography and patterns of lymph node metastasis
    Yuji Tokuda
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Am J Surg Pathol 34:1862-7. 2010
    ....
  19. doi request reprint Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins
    Stephen M Rohan
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Mod Pathol 24:1207-20. 2011
    ..The co-expression of CA9, HIF-1α, and GLUT-1 in the absence of VHL gene alterations in clear-cell papillary renal cell carcinoma suggests activation of the HIF pathway by non-VHL-dependent mechanisms...
  20. doi request reprint Anterior-predominant prostatic tumors: zone of origin and pathologic outcomes at radical prostatectomy
    Hikmat A Al-Ahmadie
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Am J Surg Pathol 32:229-35. 2008
    ..Given these similarities, long-term clinical outcomes and future molecular analyses will be necessary to assess whether true differences in biology and behavior exist between tumors of TZ and APZ origin...
  21. ncbi request reprint Epithelioid angiomyolipoma of the kidney: pathological features and clinical outcome in a series of consecutively resected tumors
    Wenlei He
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Mod Pathol 26:1355-64. 2013
    ....
  22. pmc Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome-associated Renal Cancer: Recognition of the Syndrome by Pathologic Features and the Utility of Detecting Aberrant Succination by Immunohistochemistry
    Ying bei Chen
    Departments of Pathology Medicine, Genitourinary Oncology Service Department of Surgery, Urology Service Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY Department of Pharmacology, Physiology and Neuroscience, School of Medicine, University of South Carolina, Columbia, SC
    Am J Surg Pathol 38:627-37. 2014
    ....
  23. pmc Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: a report by MSKCC and the KIRC TCGA research network
    A Ari Hakimi
    Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Clin Cancer Res 19:3259-67. 2013
    ..To investigate the impact of newly identified chromosome 3p21 epigenetic tumor suppressors PBRM1, SETD2, and BAP1 on cancer-specific survival (CSS) of 609 patients with clear cell renal cell carcinoma (ccRCC) from 2 distinct cohorts...
  24. doi request reprint Primary retroperitoneal lymph node dissection in low-stage testicular germ cell tumors: a detailed pathologic study with clinical outcome analysis with special emphasis on patients who did not receive adjuvant therapy
    Hikmat A Al-Ahmadie
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY
    Urology 82:1341-6. 2013
    ....
  25. ncbi request reprint Prognostic impact of subclassification of radical prostatectomy positive margins by linear extent and Gleason grade
    Kazuma Udo
    Department of Surgery Urology Service, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    J Urol 189:1302-7. 2013
    ..We evaluated the relationship of progression to positive surgical margin linear length and Gleason grade at a positive surgical margin...
  26. ncbi request reprint Testicular mixed germ cell tumors: a morphological and immunohistochemical study using stem cell markers, OCT3/4, SOX2 and GDF3, with emphasis on morphologically difficult-to-classify areas
    Anuradha Gopalan
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Mod Pathol 22:1066-74. 2009
    ..Embryonal carcinoma-like high-grade' nuclear details are the most important morphological criterion for the diagnosis of embryonal carcinoma in difficult-to-classify areas...
  27. doi request reprint Urachal carcinoma: a clinicopathologic analysis of 24 cases with outcome correlation
    Anuradha Gopalan
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Am J Surg Pathol 33:659-68. 2009
    ..Detailed pathologic studies with clinical outcome correlation are few...
  28. ncbi request reprint Reduced lecithin: retinol acyltransferase expression correlates with increased pathologic tumor stage in bladder cancer
    Stephen Boorjian
    Department of Urology, New York Presbyterian Hospital Weill Cornell Medical Center, New York, New York 10021, USA
    Clin Cancer Res 10:3429-37. 2004
    ..Here we evaluated expression of LRAT protein and mRNA in normal and malignant bladder tissue specimens from human patients. We also examined the effect of retinoids on LRAT expression in bladder cancer cell lines...
  29. ncbi request reprint Cluster analysis of p53 and Ki67 expression, apoptosis, alpha-fetoprotein, and human chorionic gonadotrophin indicates a favorable prognostic subgroup within the embryonal carcinoma germ cell tumor
    Madhu Mazumdar
    Memorial Sloan Kettering Cancer Center, 307 E 63rd St, 3rd Floor, New York, NY 10021, USA
    J Clin Oncol 21:2679-88. 2003
    ..We sought to determine whether simultaneous expression of one or more of these markers could identify clinically relevant subgroups of patients with nonseminomatous GCT (NSGCT)...
  30. ncbi request reprint Testicular seminoma: a clinicopathologic and immunohistochemical study of 105 cases with special reference to seminomas with atypical features
    Satish K Tickoo
    Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Int J Surg Pathol 10:23-32. 2002
    ....
  31. doi request reprint CT of renal cell carcinoma: assessment of collecting system invasion
    Christoph A Karlo
    1 Department of Radiology, Memorial Sloan Kettering Cancer Center, Radiology Academic Offices, Rm C278, 1275 York Ave, New York, NY 10065
    AJR Am J Roentgenol 201:W821-7. 2013
    ..The objective of this study was to investigate the frequency of collecting system invasion in renal cell carcinoma (RCC) and to assess the diagnostic performance of excretory phase CT for the assessment of collecting system invasion...
  32. pmc Somatic mutation of fibroblast growth factor receptor-3 (FGFR3) defines a distinct morphological subtype of high-grade urothelial carcinoma
    Hikmat A Al-Ahmadie
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, USA
    J Pathol 224:270-9. 2011
    ..Histological review could thus aid in the development of targeted inhibitors of FGFR-3 by facilitating the identification of the subset of patients most likely to harbour activating mutations in the FGFR3 gene...
  33. ncbi request reprint Immunohistochemical analysis of mucinous tubular and spindle cell carcinoma and papillary renal cell carcinoma of the kidney: significant immunophenotypic overlap warrants diagnostic caution
    Gladell P Paner
    Department of Pathology, Emory University Hospital, 1364 Clifton Road NE, G 167, Atlanta, GA 30322, USA
    Am J Surg Pathol 30:13-9. 2006
    ....
  34. ncbi request reprint Decreased expression of the human stem cell marker, Rex-1 (zfp-42), in renal cell carcinoma
    Jay D Raman
    Department of Urology, The New York Presbyterian Hospital, Weill Medical College of Cornell University, New York, NY, USA
    Carcinogenesis 27:499-507. 2006
    ..In summary, we were able to detect Rex-1 mRNA and protein expression in over 90% of normal renal parenchymal specimens and we observed a significant reduction in REX1 expression in renal tumor specimens of all histologic subtypes...
  35. ncbi request reprint Alpha-methylacyl-CoA racemase as a marker in the differential diagnosis of metanephric adenoma
    Semra Olgac
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Mod Pathol 19:218-24. 2006
    ..WT1 may be useful in separating Wilms' tumor from MA and papillary RCC but is not helpful in differentiating MA from papillary RCC...
  36. ncbi request reprint Increased expression of the polycomb group gene, EZH2, in transitional cell carcinoma of the bladder
    Jay D Raman
    Department of Urology, The New York Presbyterian Hospital, Weill Medical College of Cornell University, New York, New York 10021, USA
    Clin Cancer Res 11:8570-6. 2005
    ..We evaluated EZH2 mRNA and protein expression in bladder specimens from patients and the EZH2 mRNA expression in five bladder cancer cell lines...
  37. pmc Do prostatic transition zone tumors have a distinct morphology?
    Joaquin J Garcia
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York City, NY 10021, USA
    Am J Surg Pathol 32:1709-14. 2008
    ..Given this lack of specificity, caution should be exercised in assigning zone of origin based on this histologic appearance, especially in limited samples such as prostate needle biopsy...
  38. pmc Tumor size is associated with malignant potential in renal cell carcinoma cases
    R Houston Thompson
    Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    J Urol 181:2033-6. 2009
    ..We evaluated our experience with renal cortical tumors to determine whether tumor size is associated with malignant histology and/or nuclear grade...
  39. doi request reprint Expression of prostate-specific membrane antigen in renal cortical tumors
    Hikmat A Al-Ahmadie
    Department of Pathology, University of Chicago, Chicago, IL, USA
    Mod Pathol 21:727-32. 2008
    ....
  40. pmc Phase II trial of sunitinib in patients with metastatic non-clear cell renal cell carcinoma
    Ana M Molina
    Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
    Invest New Drugs 30:335-40. 2012
    ..6 months for the 8 papillary patients (95% CI, 1.4-7.1). The robust objective responses sunitinib had produced in clear cell RCC could not be demonstrated in this study comprised of patients with non-clear cell histologies...
  41. pmc Association of age at diagnosis and genetic mutations in patients with neuroblastoma
    Nai Kong V Cheung
    Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    JAMA 307:1062-71. 2012
    ..Neuroblastoma is diagnosed over a wide age range from birth through young adulthood, and older age at diagnosis is associated with a decline in survivability...
  42. ncbi request reprint Prognostic impact of histological subtype on surgically treated localized renal cell carcinoma
    Patrick E Teloken
    Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    J Urol 182:2132-6. 2009
    ..We evaluated our experience with tumor histology in patients with localized renal cell carcinoma...
  43. ncbi request reprint Androgen receptor expression is inversely correlated with pathologic tumor stage in bladder cancer
    Stephen Boorjian
    Department of Urology, New York Presbyterian Hospital Weill Cornell Medical Center, New York, New York, USA
    Urology 64:383-8. 2004
    ..TCC of the bladder is three times more common in males than in females. The origin of this sex difference in incidence is unknown...
  44. ncbi request reprint Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum
    Pedram Argani
    Department of Pathology, The Johns Hopkins University, Baltimore, MD 21231 2140, USA
    Am J Surg Pathol 31:1149-60. 2007
    ..Although they may be uncommon on a percentage basis, given the vast predominance of RCC in adults compared with children, adult Xp11 translocation RCC may well outnumber their pediatric counterparts...
  45. doi request reprint Prostatic transition zone directed needle biopsies uncommonly sample clinically relevant transition zone tumors
    Chadwick F Haarer
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    J Urol 182:1337-41. 2009
    ..We compared prostate cancer detected in transition zone directed needle biopsies with those in corresponding radical prostatectomy specimens...
  46. ncbi request reprint Hereditary leiomyomatosis and renal cell carcinoma (HLRCC): a rapid autopsy report of metastatic renal cell carcinoma
    Aaron M Udager
    Departments of Pathology Urology Internal Medicine, Division of Hematology and Oncology Comprehensive Cancer Center, University of Michigan Health System Michigan Center for Translational Pathology Howard Hughes Medical Institute, Ann Arbor, MI Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY
    Am J Surg Pathol 38:567-77. 2014
    ..We also detail microscopic tubular epithelial changes in the grossly uninvolved ipsilateral renal parenchyma and demonstrate sporadic, aberrant upregulation of the HIF targets GLUT1 and CAIX in dysplastic peritumoral tubules. ..
  47. doi request reprint Interobserver and intraobserver reproducibility in digital and routine microscopic assessment of prostate needle biopsies
    Paula A Rodriguez-Urrego
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Hum Pathol 42:68-74. 2011
    ....
  48. doi request reprint Fibrolamellar carcinoma of the liver exhibits immunohistochemical evidence of both hepatocyte and bile duct differentiation
    Stephen C Ward
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Mod Pathol 23:1180-90. 2010
    ..On the basis of immunohistochemistry, fibrolamellar carcinoma seems to show both hepatocellular and bile duct differentiation...
  49. ncbi request reprint Combined hepatocellular-cholangiocarcinoma: a histopathologic, immunohistochemical, and in situ hybridization study
    Satish K Tickoo
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Am J Surg Pathol 26:989-97. 2002
    ..The tumor followed an aggressive clinical course, with overall 3-and 5-year survival rates of 30% and 18%, and in the resected cases of 38% and 24%, respectively...
  50. doi request reprint Urothelial carcinoma with prominent squamous differentiation in the setting of neurogenic bladder: role of human papillomavirus infection
    Elen B Blochin
    Memorial Sloan Kettering Cancer Center, Department of Pathology, New York, NY 10065, USA
    Mod Pathol 25:1534-42. 2012
    ..The morphology of these tumors is similar to that of other high-risk HPV-associated squamous carcinomas with a basaloid, poorly differentiated appearance and little to no keratin formation...
  51. doi request reprint Differential diagnosis of renal tumours with clear cell histology
    Victor E Reuter
    Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Pathology 42:374-83. 2010
    ..Close attention to the cytological and growth pattern characteristics will allow us to arrive at the proper diagnosis, sometimes with the aid of immunohistochemistry...
  52. ncbi request reprint Five-alpha-reductase expression in benign and malignant urothelium: correlation with disease characteristics and outcome
    Daniel A Barocas
    Department of Urology, New York Presbyterian Hospital Weill Cornell Medical Center, New York, New York 10021, USA
    Urology 66:1134-9. 2005
    ....
  53. doi request reprint Role of CT in the assessment of muscular venous branch invasion in patients with renal cell carcinoma
    Christoph A Karlo
    1 Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065
    AJR Am J Roentgenol 201:847-52. 2013
    ..The purpose of this article is to determine whether the relationship between a renal cell carcinoma and the renal sinus fat on contrast-enhanced CT could predict muscular venous branch invasion and the type of surgery needed...
  54. doi request reprint Spectrum of preneoplastic and neoplastic cystic lesions of the kidney
    Ying bei Chen
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Arch Pathol Lab Med 136:400-9. 2012
    ..In the adult population, neoplasms occurring in a background of renal cystic diseases and cystic renal neoplasms often pose diagnostic challenges because of their many overlapping features...
  55. doi request reprint Cytologic findings of acquired cystic disease-associated renal cell carcinoma: a report of two cases
    Michael Rivera
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Diagn Cytopathol 36:344-7. 2008
    ..The main differential diagnosis is type 2 papillary renal cell carcinoma, from which it can be distinguished based on clinical findings only at this moment...
  56. doi request reprint Morphologic features of uterine leiomyomas associated with hereditary leiomyomatosis and renal cell carcinoma syndrome: a case report
    Karuna Garg
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Am J Surg Pathol 35:1235-7. 2011
    ..Subsequent testing confirmed a fumarate hydratase mutation. The presence of above-described nuclear features in uterine leiomyomas should raise the possibility of HLRCC...
  57. ncbi request reprint Differential expression of the enzyme that esterifies retinol, lecithin:retinol acyltransferase, in subtypes of human renal cancer and normal kidney
    Hui Chun Zhan
    Pharmacology Department, Weill Medical College, Cornell University, New York, New York 10021, USA
    Clin Cancer Res 9:4897-905. 2003
    ..This prompted us to examine the levels of LRAT (lecithin:retinol acyltransferase) protein in various subtypes of human kidney cancers relative to normal human kidney by immunohistochemistry...
  58. ncbi request reprint Anatomy of the anterior prostate and extraprostatic space: a contemporary surgical pathology analysis
    Samson W Fine
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Adv Anat Pathol 14:401-7. 2007
    ....
  59. doi request reprint Renal oncocytosis: management and clinical outcomes
    Ari Adamy
    Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    J Urol 185:795-801. 2011
    ..We describe our experience with renal oncocytosis, focusing on management and outcomes...
  60. doi request reprint Recurrent pre-existing and acquired DNA copy number alterations, including focal TERT gains, in neuroblastoma central nervous system metastases
    David Cobrinik
    Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, 10065
    Genes Chromosomes Cancer 52:1150-66. 2013
    ..Among the acquired lesions, increased TERT copy number and expression appears likely to function in lieu of MYCNA to promote CNS metastasis...
  61. pmc MYCN and MYC regulate tumor proliferation and tumorigenesis directly through BMI1 in human neuroblastomas
    Ruimin Huang
    Department of Neurology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA
    FASEB J 25:4138-49. 2011
    ....
  62. ncbi request reprint Pediatric renal cell carcinoma with oncocytoid features occurring in a child after chemotherapy for cardiac leiomyosarcoma
    Deepti Dhall
    Department of Pathology, Cedars Sinai Medical Center, Los Angeles, California, USA
    Urology 70:178.e13-5. 2007
    ..quot; Our report expands the spectrum of tumors (beyond neuroblastoma) in which RCCs with such an appearance can arise in the pediatric age group after chemotherapy...
  63. ncbi request reprint Active chemotherapy for collecting duct carcinoma of the kidney: a case report and review of the literature
    Matthew I Milowsky
    Division of Hematology and Medical Oncology, Department of Medicine, Weill Medical College of Cornell University, New York, New York 10021, USA
    Cancer 94:111-6. 2002
    ..To the authors' knowledge, there are no standard treatment regimens and neither immunotherapy nor chemotherapy have been found to be effective...
  64. ncbi request reprint Increased endocrine cells in treated rectal adenocarcinomas: a possible reflection of endocrine differentiation in tumor cells induced by chemotherapy and radiotherapy
    Jinru Shia
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Am J Surg Pathol 26:863-72. 2002
    ..The possible mechanism for the increased endocrine cells in treated rectal adenocarcinomas may be related to induction of endocrine differentiation in tumor cells by cytotoxic insult...
  65. pmc Prognostic impact of muscular venous branch invasion in localized renal cell carcinoma cases
    Andrew Feifer
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    J Urol 185:37-42. 2011
    ..To validate this presumed equivalence we compared patients with isolated muscular venous branch invasion to those with renal vein invasion and those with no confirmed vascular invasion...
  66. ncbi request reprint Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors
    William R Jarnagin
    Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Cancer 94:2040-6. 2002
    ....
  67. ncbi request reprint Salvage chemotherapy for patients with advanced pure seminoma
    Jacqueline Vuky
    Genitourinary Oncology Service, Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    J Clin Oncol 20:297-301. 2002
    ..We describe the response to conventional or high-dose salvage chemotherapy in patients with advanced seminoma who experience disease progression after receiving first-line platinum-based treatment...